Inventor
MOENNING URSULA
DE14 patents
⚠️ This page may combine multiple inventors who share the name “MOENNING URSULA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
5 patentsUS7115645B2Oct 3, 2006
1,2 diarylbenzimidazoles and their pharmaceutical use
SCHERING AG22 citations92
US6855714B2Feb 15, 2005
1-alkyl-2-aryl-benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG29 citations91
US6962932B2Nov 8, 2005
1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
SCHERING AG6 citations72
US7345075B2Mar 18, 2008
1,2 diarylbenzimidazoles and their pharmaceutical use
SCHERING AG5 citations62
US7329679B2Feb 12, 2008
1,2 Diarylbenzimidazoles and their pharmaceutical use
SCHERING AG3 citations62
BAYER AG
4 patentsUS10981932B2Apr 20, 2021
Macrocyclic indole derivatives
BAYER AG9 citations83
US11478451B1Oct 25, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11447504B2Sep 20, 2022
Macrocyclic chlorine substituted indole derivatives
BAYER AG3 citations71
US11891404B2Feb 6, 2024
Substituted macrocyclic indole derivatives
BAYER AG1 citations61
BAYER SCHERING PHARMA AG
2 patentsUS7977325B2Jul 12, 2011
3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
BAYER SCHERING PHARMA AG31 citations90
US7683081B2Mar 23, 2010
1-phenyl-2-heteroaryl-substituted benzimidazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives
BAYER SCHERING PHARMA AG0 citations51